Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1202-1208

  Ang, C W ^a   Laman, J D ^a   Willison, H J ^a   Wagner, E R ^a   Endtz, H P ^a   De Klerk, M A ^a   Tio Gillen, A P ^a   Van den Braak, N ^a   Jacobs, B C ^a   Van Doorn, P A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; LIPOPOLYSACCHARIDE;

ACUTE PHASE RESPONSE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIUM ISOLATION; BLOOD SAMPLING; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; ENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; MOLECULAR MIMICRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTYPE;

ANTIBODIES, BACTERIAL; BACTERIAL TYPING TECHNIQUES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE SEQUENCE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; LIPOPOLYSACCHARIDES; MILLER FISHER SYNDROME; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; SEROTYPING;

EID: 0036179319     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1202-1208.2002     Document Type: Article

References (37)

1. A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis
2. Rapidly progressive, predominantly motor Guillain-Barré syndrome with anti-Ga1NAc-GD1a antibodies
3. Delineation and comparison of ganglioside-binding epitopes for the toxins of Vibrio cholerae, Escherichia coli, and Clostridium tetani: Evidence for overlapping epitopes
4. Assessment of current diagnostic criteria for Guillain-Barré syndrome
5. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure
6. Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide
7. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes
8. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
9. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay
10. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome
11. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome
12. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome
13. The spectrum of antecedent infections in Guillain-Barré syndrome: A case-control study
14. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome
15. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
16. Phase variation of a beta-1,3 galactosyltransferase involved in generation of the ganglioside GM1-like lipo-oligosaccharide of Campylobacter jejuni
17. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides
18. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States
19. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: Structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher syndrome patient and from the serotype reference strain
20. Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome
21. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation
22. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside
23. Campylobacter jejuni infection and Guillain-Barré syndrome
24. Microtiter assay for detecting Campylobacter spp. and Helicobacter pylori with surface gangliosides which bind cholera toxin
25. Miller-Fisher syndrome associated with Campylobacter jejuni bearing lipopolysaccharide molecules that mimic human ganglioside GD3
26. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: Molecular mimicry and host susceptibility
27. A Campylobacter jejuni gene associated with immune-mediated neuropathy
28. Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages
29. The immunopathogenesis of Miller Fisher syndrome
30. A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18
31. Cloning of human anti-GM1 antibodies from motor neuropathy patients
32. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome
33. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside
34. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome
35. Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis
36. A bacterium lipopolysaccharide that elicits GuillainBarré syndrome has a GM1 ganglioside-like structure
37. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome